Examining the Global Genetic Prevalence of TK2d
NeuroFrontiersExamining the Global Genetic Prevalence of TK2d
Brian P. McDonough, MD, FAAFP
Austin Larson, MD
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Clinician's RoundtableImproving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Charles Turck, PharmD, BCPS, BCCCP
Caterina Garone, MD, PhD
Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
Clinician's RoundtableUncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
Charles Turck, PharmD, BCPS, BCCCP
Cristina Domínguez González, MD, PhD
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiersExploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
NeuroFrontiersQuantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiersCardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
- advertisement
